Breaking News

BioScreen Completes FDA Inspection

July 8, 2014

Inspection covered quality system and lab facilities in Torrance, CA

BioScreen Testing Services, Inc. has successfully completed an FDA audit of their lab facility in Torrance, CA, with no 483 citations issued. The inspection covered BioScreen’s quality system as well as all lab facilities, and expanded chemistry and microbiology labs. 
 
"The results from the FDA audit are extremely positive and serve as a testament to the high Quality Standards that BioScreen sets for itself," said Ranil M. Fernando, executive vice president of BioScreen.
 
BioScreen's President, Bradford Rope added, "We are extremely pleased to share this news

Related Compliance:

  • API Sourcing Trends

    Kristin Brooks, Contract Pharma||April 11, 2016
    Drug product complexities, quality and regulatory hurdles drive market shift

  • 2015 Contracting & Outsourcing Wrap-up

    2015 Contracting & Outsourcing Wrap-up

    Kristin Brooks, Contract Pharma||September 30, 2015
    A huge success, with another year of record attendance, sold-out exhibit hall, and a great line up of informative sessions

  • Setting a Precedent for Biosimilars in the U.S.

    Setting a Precedent for Biosimilars in the U.S.

    Kristin Brooks, Contract Pharma||May 19, 2015
    Niall Dinwoodie of Charles River discusses several key industry issues on biosimilars and addresses some of the development and regulatory hurdles that remain